6434
N. A. Karst et al. / Tetrahedron Letters 45 (2004) 6433–6437
intermediate 12 was synthesized from commercially
OSO3TFE
BnO OSO3TFE
O
available 1,2:5,6-di-O-isopropylidene-a-D-glucofuranose
as described in literature,11 and submitted to the two
steps sequence of sulfonation/sulfo-protection, affording
compound 13 in 87% yield (Scheme 2). Regioselective
opening of the benzylidene ring in 13 afforded 14
(93%), which was subsequently 6-O-acetylated to give
compound 15. The activation of 13 and 15 proved to
be troublesome in both cases and imidates 10 and 11
were obtained in modest 40% and 34% yield, respec-
tively. The limiting step of activation was found to be
the oxidative removal of the MP group with CAN.
NMR studies of the major side-product recovered from
the reaction revealed the presence of SO3TFE group,
which withstood the oxidative conditions of the reac-
tion, and showed perturbation of the MP aromatic sig-
nals. No formal identification of this intermediate
could be achieved.
O
PMBO
BnO
F
F
BzO
N3
1
N3
2
OBn
O
TFEO3SO
BzO
N3
OC(NH)CCl3
3
Figure 1. TFE-protected donors 1–3.
found difficult, thus we decided to investigate other
types of activation. In the GlcNp series, the a-thiophen-
ylglycosyl donor 4 was synthesized since it could either
be directly used in glycosylation or transformed into a
more reactive sulfoxide donor 5 (Scheme 1). Differen-
tially protected thiophenylglycoside 4 was synthesized
from the known thiophenylglycoside 6.8 After deacetyla-
tion and introduction of a p-methoxybenzylidene acetal
at the 4,6-positions, the remaining 3-hydroxyl was benz-
ylated, to give 8 in 80% yield. Regioselective opening of
the benzylidene acetal by treatment with Bu2BOTf9
afforded the expected 6-hydroxyl derivative 9 in 91%
yield. Selectivity was confirmed by NMR studies and
subsequent acetylation of the primary position. Intro-
duction of SO3TFE at the 6-position was achieved in
two steps, sulfonation and sulfo protection with a
freshly prepared solution of trifluorodiazoethane10 in
presence of citric acid, affording donor 4 in 70% yield.
Subsequent oxidation of 4 with mCPBA afforded the
corresponding sulfoxide donor 5.
Donors 1–4, 10, and 11 were investigated under a variety
of glycosylation conditions with acceptors 17, 18,7 19,12
and 2012 (Fig. 2). The strong electron-withdrawing char-
acter of the SO3TFE group was an initial concern in the
glycosylation reactions. Its presence contributed to dis-
arm the sugar, and it was expected that the reactivity
of both donors and acceptors would be lowered. To
our satisfaction, glycosylation of a reactive acceptor
17, with fluorides, sulfide, and imidate donors gave good
to excellent results (Table 1, entries 1–5, 7–8). Partial
loss of the PMB protection was observed under Ag-
ClO4/Cp2ZrCl2 initiation used with fluoride donor 1.
The use of acid scavenger, norbornylene,13 did not
The uronic acid residues in GAGs, both GlcAp (chon-
droitin sulfate D) and IdoAp (heparin, dermatan sul-
fate) units can contain 2-O-sulfo groups. For example,
IdoA2SO3 is an essential saccharide residue in the hepa-
rin pentasaccharide structure that binds to antithrom-
bin, promoting its anticoagulant activity. Thus, we
next directed our studies toward the preparation of the
2-sulfo protected uronic acid precursors glucose (Glcp).
2-SO3TFE protected Glcp derivatives 10 and 11 were
prepared to study the influence of SO3TFE protecting
group, in the critical 2-position, on the outcome of the
glycosylation reaction stereoselectivity. The common
O
O
Ph
Ph
O
a
O
O
O
OMP
c
BnO
BnO
TFEO3SO
OR
OC(NH)CCl3
12 R = H
b
10
13 R = SO3TFE
OR6
O
OAc
O
a
BnO
BnO
TFEO3SO
BnO
BnO
OMP
OC(NH)CCl3
OSO3TFE
14 R6 = H
15 R6 = Ac
11
d
Scheme 2. Reagents and conditions: (a) (i) CAN, MeCN, PhMe, H2O;
(ii) Cl3CCN, DBU, DCM 10 40%, 11 34%; (b) (i) Me3NÆSO3, D MF,
50°C; (ii) TFEN2, citric acid, MeCN 87% (two steps); (c) BH3ÆTHF,
Bu2BOTf 93%; (d) Ac2O, pyridine 99%.
OAc
O
O
R3O
7: R3 = H
PhOMe
O
a
O
AcO
AcO
N3
N
SPh
3 SPh
6
b
8: R3 = Bn
c
OH
O
COOMe
O
O
OSO3TFE
O
OH
O
ClAcO
BnO
O
d
PMBO
BnO
PMBO
BnO
BzO
O
OC(NH)CCl3
O
16
17
N
3 R
N3
SPh
9
4: R = SPh
e
OSO3TFE
O
OTBDMS
O
COOMe
O
5: R = SOPh
HO
HO
HO
OTDS
OBn
OMP
BnO
BzO
BnO
Scheme 1. Reagents and conditions: (a) (i) MeONa, MeOH; (ii)
MeOPhCH(OMe)2, CSA, MeCN 82% (two steps, a:b 7:1); (b) NaH,
BnBr, DMF 80%; (c) BH3ÆTHF, Bu2BOTf 91%; (d) (i) Me3NÆSO3,
DMF, 50°C; (ii) TFEN2, citric acid, MeCN 70% (two steps); (e)
mCPBA, DCM 86%.
N3
OBz
OSO3TFE
18
19
20
Figure 2. Donor 16 and acceptors 17–20 employed in the glycosylation
reactions.